Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

HSIC · Henry Schein, Inc.

$87.30 -0.76% Sep 10 close
Detected setup watchlist_candidate · Setup Score 0/100

Stand aside — setup invalidated

Setup score 0, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about HSIC

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$HSIC

Henry Schein, Inc.

Henry Schein, Inc. is a mid-cap Medical Distributors company in the Distribution Services sector with a market cap of $10B.

Distribution Services Medical Distributors stock Stage 2 · Advancing Base 2
$87.30 latest close
Verdict · setup score 0/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 0, but distribution days reach 5 or more — stand aside until the condition resets.

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

HSIC-0.76%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. -0.16 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-0.76% From the open-1.02% Range position17% GapNo gap
QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $87.30 -0.8% Sep 10 close
52W High $92.18 5.3% below high
Wks Since High 0w 5w today
Base Depth 3.9% 5.6% today
RS Rank 34 percentile of scan
SMA 50 $87.66
Avg Vol 1,196,928
Rel Vol (Sep 10) 1.28×
More stats
52W Low $61.94
Tight Wks 0
Base B2
SMA 200 $79.34
RS Line vs High -5.0%
RS Line Slope -0.6% ▼
Group Rank #38/58
ADR% 1.8%
ATR(14) $1.61 (1.8%)
Vol Pace (live) N/A
U/D Vol 0.51
A/D Days 16A / 9D
A/D Rating A+
VDU Bars 0/10 d
Position in 52-week range 84thpercentile of the 52-week range
$61.94low
$92.18high

HSIC Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for HSIC.

Create Free Account

Technical Analysis Report Card

$HSIC · $87.30 · as of 2026-09-10 · multi-factor read
39
/ 100
Technicals 39/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▬ Sideways / consolidating
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$87.66 ↓
100-day$82.13 ↑
200-day$79.34 ↑
Bullish (50 > 200)

RSI (14)

Reading43.3 · Bearish

Bearish momentum — sellers in control.

MACD (12/26/9)

StateWeakening
Histogram-0.410

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width-8% · 4.0%
Squeeze — volatility compressing

Piercing the lower band — capitulation or strong selling. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.51 · Distribution
Rel volume1.28×

Distribution — volume is concentrated on down days; sellers dominate. Recent volume is easing versus its baseline.

Support & Resistance

R · $87.72swing level
R · $89.31swing level
R · $91.8652-week high
Price · $87.30now
S · $82.77swing level
S · $78.62swing level
S · $76.17swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$86.64
38.2%$83.21
50.0%$80.44
61.8%$77.67
78.6%$73.72

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for HSIC — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Above 200-day MA50/200 bullishVolume distribution
Want this read in a legend's voice? Ask a Legend about HSIC
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 4 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini C

Trend-template read: fails Price > 50-day MA.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $87.30, MA150 $80.42, MA200 $79.34
1.2 150-day MA > 200-day MAMA150 $80.42 vs MA200 $79.34
Failing evidence
1.5 Price > 50-day MAPrice $87.30 vs MA50 $87.66
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 43
5/9 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high5.3% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 1.84%
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 43
C: Quarterly EPS acceleration ≥ 25%Data unavailable
2/8 checks
Watch
Weinstein D

Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $87.30 vs MA200 $79.34
Failing evidence
Volume expansion above averageVolume ratio 1.28x
Relative strength ≥ 60RS 43
3/6 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$87.30
Volume vs average1.28x
Failing evidence
Relative strengthRS 43
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$87.30
Volume vs average1.28x
Failing evidence
Relative strengthRS 43
Box top broken on heavy volumeNot confirmed
4/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$87.30
Volume vs average1.28x
Failing evidence
Relative strengthRS 43
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
111RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +2 A+
A: 14 D: 12 Net: +265 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met
C 2/7 criteria
Separate score from the Minervini Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
Revenue growth ≥20% YoY +4%
Gross margin ≥30%
ROE ≥17%
RS rating ≥80 (leadership) 43
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -5.3%

Method Playbook

Trade it like Weinstein EXACT LEVELS · PRO
Weinstein D · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

0 setup score
RS Score 43
Trend template 6/8
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met
  • A relative-strength leader — not met RS rank 34 — laggard
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Clear of earnings — partly met Report date unknown
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 1.3× average — light
  • In a confirmed uptrend — met Stage 2 · Trend template 6/8
Why these seven? → The Universal Edge

Minervini Trend Template

6/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $87.30 vs SMA150 $80.42 / SMA200 $79.34
SMA 150 above SMA 200 SMA150 $80.42 vs SMA200 $79.34
SMA 200 trending up Slope +2.05 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $87.66
Price above SMA 50 $87.30 vs SMA50 $87.66
30%+ above 52-week low +40.9% from $61.94
Within 25% of 52-week high -5.3% from $92.18
RS score above 70 RS 43

Fundamentals

52W Range
84%
Mkt Cap SEC
9.7B
Rev YoY
+4%
EPS TTM
$3.27
P/E TTM
26.7x
Float
111M

Company

Company profile
Henry Schein, Inc.
HSIC · NASDAQ · Distribution Services · Medical Distributors

Scan History

3× streak
Sep 09: 70 (Trend Only)Sep 09: 71 (Trend Only)Sep 10: 69 (Trend Only)Sep 11: 0 (watchlist_candidate)Sep 11: 69 (Trend Only)Sep 11: 69 (Trend Only)69
Sep 11
Trend Only ✓ Gate
69
Sep 11
Trend Only ✓ Gate
69
Sep 11
watchlist_candidate
0
Sep 10
Trend Only ✓ Gate
69 0.0%
Sep 09
Trend Only ✓ Gate
71 -0.8%
Sep 09
Trend Only ✓ Gate
70 -0.8%

Get the full picture on HSIC

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial